| Patents for A61P 37 - Drugs for immunological or allergic disorders (117,141) |
|---|
| 07/18/2007 | CN1326565C Potentiator for antibody against lymphoid tumor |
| 07/18/2007 | CN1326563C Use of the long pentraxin PTX3 for the preparation of medicament for the prevention and cure of autoimmune pathologies |
| 07/18/2007 | CN1326560C Use of POLY-GLU,TYR treated therewith for neuroprotective therapy |
| 07/18/2007 | CN101001857A 2-(pyridin-2-ylamino)-pyrido [2,3-d]pyrimidin-7-ones |
| 07/18/2007 | CN101001847A 2-carbamide-4-phenylthiazole derivatives, preparation thereof and therapeutic use thereof |
| 07/18/2007 | CN101001833A Organic compounds |
| 07/18/2007 | CN101001646A Stabilized synthetic immunogen delivery system |
| 07/18/2007 | CN101001628A Anti-HIV quinuclidine compounds |
| 07/18/2007 | CN101001626A Pyrazole derivatives for treating conditions mediated by activation of the adenosine A2b or A3 receptor |
| 07/18/2007 | CN100999616A Preparation process of squid ink black pigment and application thereof |
| 07/18/2007 | CN100998864A Cyclosporin A semisolid skeleton capsule and its preparation method |
| 07/18/2007 | CN100998857A Kidney tonifying and enriching blood health-care tea and its preparation method |
| 07/18/2007 | CN100998790A Shennong sibao liquid health-care medicine and its preparing method |
| 07/18/2007 | CN100998693A Health-care medicated wine made of traditional Chinese medicines |
| 07/18/2007 | CN100998631A Medicine form of low toxin thunder godvine extract by using new processing method |
| 07/18/2007 | CN100998611A Huishuhua fermentation preparation process using Chinese herb medicine as medium |
| 07/18/2007 | CN100998573A Effect and use of capusle prepared by blending multiple sola-red-agent |
| 07/18/2007 | CN100998551A Oral cavity quick dissolved film containing civeran, and method for preparing the same |
| 07/18/2007 | CN100998417A Application of power of whole cannabis sativa seeds for preparing functional food with function of improving immunity of human |
| 07/18/2007 | CN100998416A Application of edestin for preparing functional food with function of improving immunity of human |
| 07/18/2007 | CN100998415A Application of edestin for preparing functional food with function of improving immunity of human |
| 07/18/2007 | CN100998406A Health-care food with functions of improving immunocompetence and protecting damaged gastric mucosa and its preparing method |
| 07/18/2007 | CN100998405A Health-care food used for regulating immunocompetence of human and its production method |
| 07/18/2007 | CN100998403A Composite nutrition nourishing containing Chinese wolfberry |
| 07/18/2007 | CN100998378A Bait used specially for atlantic trout |
| 07/17/2007 | USRE39734 Selenium source, a glutathione precursor of glutamic acid, cystine and glycine; increasing the content of glutathione in body tissue above that of a pretreatment level, enhancing immune activity |
| 07/17/2007 | US7244832 host cell tranformed with a nucleic acid encoding an antibody having a composite heavy chain with a variable domain including complementarity determining regions and framework regions comprising human acceptor antibody heavy chain framework region residues |
| 07/17/2007 | US7244819 Fusion polypeptides, vaccines and compositions of FKBP chaperones and target polypeptides |
| 07/17/2007 | US7244818 Interferon alpha responsive protein |
| 07/17/2007 | US7244753 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 07/17/2007 | US7244746 Imidazolyl derivatives as corticotropin releasing factor inhibitors |
| 07/17/2007 | US7244741 Fredericamycin derivatives as medicaments for treating tumours |
| 07/17/2007 | US7244711 Mixtures of enzyme inhibitors and free radical scavengers selected from phenolic compounds, phenothiazines and diphenylamines, used for prophylaxis of rheumatic diseases, pancreatitis, multiple sclerosis or gastrointestinal disorders |
| 07/17/2007 | US7244615 Producing an antibody comprising complementarity determining regions, heavy and light chains, and non-human donor residues, a variable domain; used for in vivo therapy and diagnosis |
| 07/17/2007 | US7244589 Chimeric immunogens |
| 07/17/2007 | US7244429 Antibody selective for a tumor necrosis factor-related apoptosis-inducing ligand receptor and uses thereof |
| 07/17/2007 | CA2388639C Inhibitors of .alpha.l.beta.2 mediated cell adhesion |
| 07/17/2007 | CA2373944C Cathecol hydrazone derivatives, process for preparing the same and pharmaceutical composition containing the same |
| 07/17/2007 | CA2298445C Method and compositions for treating late phase allergic reactions and inflammatory diseases |
| 07/17/2007 | CA2279960C Synthesis of terfenadine and derivatives |
| 07/17/2007 | CA2182013C Humanized antibodies against leukocyte adhesion molecule vla-4 |
| 07/17/2007 | CA2172506C Mycophenolate mofetil and mycophenolic acid high dose oral suspensions |
| 07/17/2007 | CA2160161C Use of derivatives of 2,4-bisubstituted phenols as 5-lipoxigenase inhibitors |
| 07/12/2007 | WO2007078202A1 Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (nait) |
| 07/12/2007 | WO2007077949A1 Heterocyclic janus kinase 3 inhibitors |
| 07/12/2007 | WO2007077861A1 NF-κB INHIBITOR |
| 07/12/2007 | WO2007077812A1 Pharmaceutical having anti-histamine activity |
| 07/12/2007 | WO2007076950A1 Anti-cd19 antibodies with reduced immunogenicity |
| 07/12/2007 | WO2007076776A1 Method and device for vacuum drying papaya latex |
| 07/12/2007 | WO2007062107A3 Immunostimulatory oligoribonucleotides |
| 07/12/2007 | WO2007061948A3 Substituted 5-heteroaryl-1-phenyl-pyrazole cannabinoid modulators |
| 07/12/2007 | WO2007054279A8 Cyclic-dinucleotides and its conjugates as adjuvants and their uses in pharmaceutical compositions |
| 07/12/2007 | WO2007034279A3 C3a antagonists and pharmaceutical compositions thereof |
| 07/12/2007 | WO2007011606A3 USE OF HMGBl ANTAGONISTS FOR THE TREATMENT OF INFLAMMATORY SKIN CONDITIONS |
| 07/12/2007 | WO2007007159A3 Anti-madcam antibodies to treat uterine disorders |
| 07/12/2007 | WO2007006041A8 Imaging and therapeutic method using monocytes |
| 07/12/2007 | WO2007002261A3 IL-1β BINDING ANTIBODIES AND FRAGMENTS THEREOF |
| 07/12/2007 | WO2006116458B1 Modified oligoribonucleotide analogs with enhances immunostimulatory activity |
| 07/12/2007 | US20070161707 Pharmaceutical uses for alpha2delta ligands |
| 07/12/2007 | US20070161706 Pharmaceutical uses for alpha2delta ligands |
| 07/12/2007 | US20070161681 Ether derivatives useful as inhibitors of pde4 isozymes |
| 07/12/2007 | US20070161666 Pyrrolo[2,3-d]pyrimidine compounds |
| 07/12/2007 | US20070161647 QUINOLINE-4-CARBOXAMIDE DERIVATIVES AS NK-3 and NK-2 RECEPTOR ANTAGONISTS |
| 07/12/2007 | US20070161646 Piperidine Derivatives and Their Use as Modulators of Chemokine Receptor Activity (Especially CCR5) |
| 07/12/2007 | US20070161635 Kinase inhibitors |
| 07/12/2007 | US20070161607 immunosuppressive treatment of autoimmune disorders or inflammatory diseases; [Tris-(4-fluoro-phenyl)-methyl]-phosphonic acid dimethyl ester; Gardos channel antagonists |
| 07/12/2007 | US20070161585 Immunopotentiator and method for enhancing immunoactivity using the same |
| 07/12/2007 | US20070161557 Increasing hematopoiesis; treating glucosuria, hyperglycemia and diabetes; thrombocytopenia |
| 07/12/2007 | US20070161083 Codon Optimized Recombinant Dermaphagoides Allergens |
| 07/12/2007 | US20070161046 Truncated aggrecanase molecules |
| 07/12/2007 | US20070160627 wherein IL1 beta R coding sequence has been inactivated for use in immunotherapy and vaccination, wherein MVA mutant comprises DNA sequences coding for a heterologous protein derived from therapeutic polypeptides and polypeptides of pathogenic agents, wherein MVA mutant leads to enhanced memory response |
| 07/12/2007 | US20070160603 Antibodies Against Tumor Necrosis Factor Delta (APRIL) |
| 07/12/2007 | US20070160600 Compositions and methods of monoclonal and polyclonal antibodies specific for T cell subpopulations |
| 07/12/2007 | US20070160594 Method of Diagnosing and Treating Cartilaginous Disorders |
| 07/12/2007 | US20070160570 Chimeric polypeptides containing chemokine domains |
| 07/12/2007 | US20070160567 Allergen suppressor, allergen-suppression processed fiber and method of producing the same |
| 07/12/2007 | US20070160527 Use of n-acetyl-d-aminoglycosamine in treatment of local lesions or systematic symptoms related to autoimmune reactions |
| 07/12/2007 | DE4208258B4 Verfahren zur Herstellung von kristallinem Ciclosporin in kugelartiger Teilchenform und seine Verwendung, insbesondere zur pulmonalen Verabreichung A process for producing crystalline Ciclosporin in spheroidal particulate form and to its use, in particular for pulmonary administration |
| 07/12/2007 | CA2636265A1 Preparation useful for, and method for treatment of neonatal alloimmune thrombocytopenia (nait) |
| 07/12/2007 | CA2635850A1 Heterocyclic janus kinase 3 inhibitors |
| 07/12/2007 | CA2635623A1 Anti-cd19 antibodies with reduced immunogenicity |
| 07/12/2007 | CA2630364A1 Methods of treating unwanted immune response with random copolymers |
| 07/11/2007 | EP1806404A1 Isolated nucleic acid molecules which encode T cell inducible factors, or interleukin-21, the proteins encoded, and uses thereof |
| 07/11/2007 | EP1806402A2 CTLA4/CD28 ligands and uses therefor |
| 07/11/2007 | EP1806360A2 Novel expression vectors containing accessory molecule ligand genes and their use for immunomodulation and treatment of malignancies and autoimmune disease |
| 07/11/2007 | EP1806338A1 Process for producing 2-amino-2-[2-[4-(3-benzyloxyphenylthio)-2-chlorophenyl[ethyl]-1,3-propanediol hydrochloride or hydrate thereof and intermediate for the same |
| 07/11/2007 | EP1806147A1 Use of immunesuppressant receptor |
| 07/11/2007 | EP1806146A1 Agonists or antagonists of cutaneous T cell-attracting chemokine (CTACK) or vasoactive intestinal contractor (VIC) chemokines |
| 07/11/2007 | EP1806143A2 Baff receptor (BCMA), an immunoregulatory agent |
| 07/11/2007 | EP1806141A1 Par-2 antagonists |
| 07/11/2007 | EP1806139A2 Immune stimulation using chemically modified RNA |
| 07/11/2007 | EP1805510A1 Therapeutic strategy for treating autoimmune and degenerative diseases |
| 07/11/2007 | EP1804828A2 The use of a protease or a protease inhibitor for the manufacture of medicaments |
| 07/11/2007 | EP1366021B1 Substituted diarylureas as stimulators for fas-mediated apoptosis |
| 07/11/2007 | EP1303265B1 Use of cox-2 inhibitors as immunostimulants in the treatment of hiv or aids |
| 07/11/2007 | EP1289535B1 Apoptotic entities for use in treatment of neurodegenerative and other neurological disorders |
| 07/11/2007 | EP1242108B1 Optimized minigenes and peptides encoded thereby |
| 07/11/2007 | EP1218504B1 Gl50 molecules and uses therefor |
| 07/11/2007 | EP1105467B1 USE OF MODIFIED LYSOZYME c TO PREPARE MEDICINAL COMPOSITIONS FOR THE TREATMENT OF SOME SERIOUS DISEASES |
| 07/11/2007 | EP1037917B1 Recombinant nodavirus compositions and methods |